Iqvia Holdings Inc. (IQV) Revenue by Segment

Iqvia revenue by segment at a glance

In Q2 fiscal 2026 (the quarter ended June 30, 2026), Iqvia's largest business segment was Research and Development Solutions, with $2.58 billion or 59% of revenue, up 8.8% from a year earlier. Next: Commercial Solutions (41%).

By region, Americas brought in 47%, EMEA brought in 32% and Asia Pacific brought in 21% of revenue in Q2 fiscal 2026.

The fastest-growing business segment from a year earlier was Research and Development Solutions (+8.8%).

From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.

Iqvia Holdings Inc.

IQVHealthcare

United States

Healthcare

Revenue breakdown

Fiscal quarters, from company filings

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

Research and Development SolutionsTechnology and Analytics SolutionsCommercial SolutionsContract Sales and Medical Solutions

Q2 FY26 breakdown

Fiscal quarter ended Jun 30, 2026

Item	Revenue	Share	vs year before	Trend
Research and Development Solutions	USD 2.58B	59.0%	+8.8%
Commercial Solutions	USD 1.79B	41.0%	+8.6%

Sum of items USD 4.37B. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18	Q1 FY18	Q4 FY17	Q3 FY17
Research and Development Solutions	2.6B	2.4B	2.3B	2.3B	2.4B	2.3B	2.1B	2.2B	2.1B	2.1B	2.2B	2.1B	2.1B	2.0B	2.1B	2.0B	1.9B	1.9B	1.9B	1.9B	1.9B	1.9B	1.7B	1.4B	1.2B	1.4B	1.5B	1.5B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	–	1.3B
Technology and Analytics Solutions	–	–	1.8B	1.6B	–	–	1.7B	1.6B	1.5B	1.5B	1.5B	1.4B	1.5B	1.4B	1.5B	1.4B	1.4B	1.4B	1.5B	1.3B	1.4B	1.3B	1.4B	1.2B	1.1B	1.1B	1.2B	1.1B	1.1B	1.1B	1.1B	1.0B	1.0B	985.0M	–	898.0M
Commercial Solutions	1.8B	1.8B	–	–	1.7B	1.6B	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Contract Sales and Medical Solutions	–	–	210.0M	209.0M	–	–	177.0M	180.0M	172.0M	189.0M	186.0M	183.0M	176.0M	182.0M	182.0M	183.0M	183.0M	195.0M	196.0M	201.0M	194.0M	193.0M	189.0M	179.0M	177.0M	196.0M	210.0M	208.0M	203.0M	193.0M	193.0M	198.0M	206.0M	213.0M	–	227.0M

Iqvia revenue by business segment, last 4 quarters

Business segment	Q2 FY26	Q1 FY26	Q3 FY25	Q2 FY25	Share
Research and Development Solutions	$2.6B	$2.4B	$2.3B	$2.4B	59%
Commercial Solutions	$1.8B	$1.8B	–	$1.7B	41%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Iqvia revenue by region, last 4 quarters

Region	Q2 FY26	Q1 FY26	Q3 FY25	Q2 FY25	Share
Americas	$2.0B	$2.0B	$1.9B	$1.9B	47%
EMEA	$1.4B	$1.4B	$1.3B	$1.2B	32%
Asia Pacific	$920.0M	$812.0M	$870.0M	$841.0M	21%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Questions and answers

What are Iqvia's business segments?

Research and Development Solutions and Commercial Solutions (as reported for Q2 fiscal 2026).

Which business segment makes the most money for Iqvia?

Research and Development Solutions: $2.58 billion, or 59% of revenue, in Q2 fiscal 2026.

Where does Iqvia make its money?

By region in Q2 fiscal 2026: Americas (47%), EMEA (32%) and Asia Pacific (21%).

MoreIqvia stock overview Iqvia financials Iqvia executive team Iqvia shareholders

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.